Passive heat therapy for lowering systolic blood pressure and improving vascular function in mid-life and older adults

被动热疗可降低中年和老年人的收缩压并改善血管功能

基本信息

  • 批准号:
    10712162
  • 负责人:
  • 金额:
    $ 37.56万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-04-01 至 2028-03-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Aging is the primary risk factor for Alzheimer’s disease and related dementias, as well as mild cognitive impairment (MCI). Above-normal systolic blood pressure (SBP; ≥120 mmHg) further increases risk of dementias, due, in part, to SBP-associated cerebrovascular dysfunction, i.e., impaired cerebral blood flow regulation. Accordingly, midlife and older adults with above-normal SBP are at the highest risk for cognitive decline driven by vascular contributions to cognitive impairment and dementias in this age group. Excessive reactive oxygen species-induced oxidative stress and reductions in nitric oxide (NO) bioavailability within the cerebral vasculature likely mediate cerebrovascular dysfunction with aging and contribute to MCI and Alzheimer’s disease and related dementias in those with above-normal SBP. Passive heat therapy (regular short-term increases in body core temperature) is an established lifestyle practice in certain cultures (e.g., sauna bathing in Finland; hot spring bathing in Japan) and may be effective for decreasing risk of dementias. Epidemiological research suggests regular sauna use is associated with ~65% lower incidence of dementias, supporting heat therapy as a powerful candidate approach to significantly reduce risk of dementias. However, randomized controlled trials are urgently needed to establish the causal link between passive heat therapy and risk factors for MCI, Alzheimer’s disease and related dementias. Results from our pilot trial show that 8-10 weeks of heat therapy (hot water immersion 3x1 h/week) lowered SBP (-10 mmHg) and improved cognitive performance and cerebrovascular function vs. sham (thermoneutral water immersion). Heat therapy also reduced vascular markers of oxidative stress and increased NO bioavailability. Our parent award is a randomized clinical trial assessing 3 months (36 x 1 h sessions) of passive heat therapy vs. sham immersion for lowering SBP and improving peripheral vascular function in midlife and older adults with SBP 120-139 mmHg. This proposal will extend the work of our parent grant by assessing the efficacy of heat therapy for: 1) increasing key domains of cognitive performance; 2) improving cerebrovascular blood flow and other measures of cerebrovascular function and health that are closely linked to MCI and dementias; and 3) decreasing oxidative stress and increasing NO-bioavailability, important mechanisms likely underlying cognitive impairment and dementias. This research is highly relevant to MCI and Alzheimer’s disease and related dementias, as it will evaluate a novel lifestyle-based therapy for improving key risk factors for these disorders. Leveraging our existing clinical trial, we will provide the first evidence for the efficacy of passive heat therapy for enhancing cognitive and cerebrovascular function in older adults at risk of developing MCI and Alzheimer’s disease and related dementias. Lastly, the proposed research will also stimulate future research promoting translation of this promising lifestyle intervention to other at-risk groups.
项目摘要 衰老是阿尔茨海默氏病和相关痴呆症的主要危险因素,也是轻度认知 损害(MCI)。高正常的收缩压(SBP;≥120mmHg)进一步增加了 痴呆症,部分原因是SBP相关的脑血管功能障碍,即脑血流受损 规定。彼此之间,中年和老年人具有高度SBP的认知风险最高 该年龄段的认知障碍和痴呆症的血管贡献驱动的下降。 过量的活性氧诱导的氧化应激和一氧化氮(NO)生物利用度的减少 在脑脉管系统中,可能会介导脑血管功能障碍,并导致MCI 以及高于正常的SBP患者的阿尔茨海默氏病和相关痴呆症。 被动热疗法(定期短期体内核心温度升高)是已建立的生活方式 在某些文化中练习(例如,芬兰的桑拿浴浴;日本的温泉沐浴),可能是有效的 降低痴呆症的风险。流行病学研究表明,定期使用桑拿与 痴呆症的降低〜65%,支持热疗法作为一种强大的候选方法 降低痴呆症的风险。但是,迫切需要进行随机对照试验来建立因果关系 被动热疗法与MCI,阿尔茨海默氏病和相关痴呆症的危险因素之间的联系。 我们的试点试验的结果表明,降低了8-10周的热疗法(热水浸入3x1 h/周) SBP(-10 mmHg)和改善的认知表现和脑血管功能与假手术 (热水浸入)。热疗法还降低了氧化应激的血管标志物和 没有增加生物利用度。 我们的父母奖是一个被动热疗法的3个月(36 x 1 h会话)的随机临床试验评估 与降低SBP和改善中年和老年人外周血管功能的假手术浸入 与SBP 120-139 mmHg。该提案将通过评估效率来扩大我们父母赠款的工作 热疗法的:1)增加认知表现的关键领域; 2)改善脑血管血液 与MCI紧密相关的脑血管功能和健康的其他措施 痴呆症; 3)减少氧化应激和提高无生物的胁迫,重要机制可能 潜在的认知障碍和痴呆症。这项研究与MCI和阿尔茨海默氏症高度相关 疾病和相关痴呆症,因为它将评估一种新型基于生活方式的治疗,以改善关键危险因素 对于这些疾病。利用我们现有的临床试验,我们将提供第一个证据 被动热疗法可增强有发展风险的老年人认知和脑血管功能 MCI和阿尔茨海默氏病和相关痴呆症。最后,拟议的研究还将刺激未来 研究将这种有希望的生活方式干预转化为其他高危群体的研究。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DOUGLAS R SEALS其他文献

DOUGLAS R SEALS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DOUGLAS R SEALS', 18)}}的其他基金

Passive heat therapy for lowering systolic blood pressure and improving vascular function in mid-life and older adults
被动热疗可降低中年和老年人的收缩压并改善血管功能
  • 批准号:
    10596067
  • 财政年份:
    2022
  • 资助金额:
    $ 37.56万
  • 项目类别:
Targeting cellular senescence to prevent accelerated vascular aging induced by the common chemotherapeutic agent doxorubicin
靶向细胞衰老以防止常见化疗药物阿霉素引起的加速血管老化
  • 批准号:
    10505896
  • 财政年份:
    2022
  • 资助金额:
    $ 37.56万
  • 项目类别:
Targeting cellular senescence to prevent accelerated vascular aging induced by the common chemotherapeutic agent doxorubicin
靶向细胞衰老以防止常见化疗药物阿霉素引起的加速血管老化
  • 批准号:
    10684719
  • 财政年份:
    2022
  • 资助金额:
    $ 37.56万
  • 项目类别:
Passive heat therapy for lowering systolic blood pressure and improving vascular function in mid-life and older adults
被动热疗可降低中年和老年人的收缩压并改善血管功能
  • 批准号:
    10375083
  • 财政年份:
    2022
  • 资助金额:
    $ 37.56万
  • 项目类别:
Mitochondrial-targeted antioxidant supplementation for improving age-related vascular dysfunction in humans
线粒体靶向抗氧化剂补充剂可改善人类与年龄相关的血管功能障碍
  • 批准号:
    10538571
  • 财政年份:
    2021
  • 资助金额:
    $ 37.56万
  • 项目类别:
Inspiratory muscle strength training for lowering blood pressure and improving endothelial function in postmenopausal women: comparison with "standard of care" aerobic exercise
用于降低绝经后妇女血压和改善内皮功能的吸气肌力量训练:与“标准护理”有氧运动的比较
  • 批准号:
    10414050
  • 财政年份:
    2021
  • 资助金额:
    $ 37.56万
  • 项目类别:
Inspiratory muscle strength training for lowering blood pressure and improving endothelial function in postmenopausal women: comparison with "standard of care" aerobic exercise
用于降低绝经后妇女血压和改善内皮功能的吸气肌力量训练:与“标准护理”有氧运动的比较
  • 批准号:
    10178631
  • 财政年份:
    2021
  • 资助金额:
    $ 37.56万
  • 项目类别:
Mitochondrial-targeted antioxidant supplementation for improving age-related vascular dysfunction in humans
线粒体靶向抗氧化剂补充剂可改善人类与年龄相关的血管功能障碍
  • 批准号:
    10319609
  • 财政年份:
    2021
  • 资助金额:
    $ 37.56万
  • 项目类别:
Inspiratory muscle strength training for lowering blood pressure and improving endothelial function in postmenopausal women: comparison with "standard of care" aerobic exercise
用于降低绝经后妇女血压和改善内皮功能的吸气肌力量训练:与“标准护理”有氧运动的比较
  • 批准号:
    10576933
  • 财政年份:
    2021
  • 资助金额:
    $ 37.56万
  • 项目类别:
Nicotinamide riboside supplementation for treating elevated systolic blood pressure and arterial stiffness in middle-aged and older adults
补充烟酰胺核苷治疗中老年人收缩压升高和动脉僵硬度
  • 批准号:
    10358491
  • 财政年份:
    2019
  • 资助金额:
    $ 37.56万
  • 项目类别:

相似海外基金

Developing a culturally adapted implementation program for teleophthalmology use in Latinx communities
制定适合拉丁裔社区远程眼科使用的文化适应实施计划
  • 批准号:
    10771837
  • 财政年份:
    2023
  • 资助金额:
    $ 37.56万
  • 项目类别:
Deciphering brain mosaicism in drug-resistant epilepsy at cellular resolution
在细胞分辨率下解读耐药性癫痫中的大脑镶嵌现象
  • 批准号:
    10841995
  • 财政年份:
    2023
  • 资助金额:
    $ 37.56万
  • 项目类别:
IGNITE Cost Extension - Admin Supplement
IGNITE 成本扩展 - 管理补充
  • 批准号:
    10820198
  • 财政年份:
    2023
  • 资助金额:
    $ 37.56万
  • 项目类别:
Function of RUNX1 in diverse Down syndrome tissues
RUNX1在多种唐氏综合症组织中的功能
  • 批准号:
    10853906
  • 财政年份:
    2023
  • 资助金额:
    $ 37.56万
  • 项目类别:
SIREN Administrative Supplement
SIRN 行政补充
  • 批准号:
    10625116
  • 财政年份:
    2022
  • 资助金额:
    $ 37.56万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了